Q + short-term catalysts= price per share going due North soon
* share buy-backs * clinical trials * increasing revs * increasing profits * efforts of greatly expanded sales force * more indications being marketed * dividends * potential dividend increases * expect with positive news BIG MONEY will start accumulating * Synacthen * Biovectra * Q still very cheap on p/e & peg basis so value investors will start coming on board. More and more to like about The Q every day. And with all this going on, share price is still lower than last year! ps and combine all the good with the large (insane?) short position and Q is on the launch pad, fuse is lit....all systems go!